Back to Authors

Yang, Ju Dong

https://orcid.org/0000-0001-7834-9825

Mayo Clinic

Cedars-Sinai Medical Center

Citations 82

Faculty Opinions recommendation of Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.
Yang, Ju Dong , Roberts, Lewis R. , Yang, Ju Dong

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | July 31, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.13471974.14851081 Get It

Genes Associated with Recurrence of Hepatocellular Carcinoma: Integrated Analysis by Gene Expression and Methylation Profiling
Yang, Ju Dong , Seol, So‐Young, Leem, Sun-Hee, Kim, Yong‐Hoon , Sun, Zhifu , Lee, Ju‐Seog , Thorgeirsson, Snorri S., Chu, In‐Sun , Roberts, Lewis R. , Kang, Koo Jeong , Yang, Ju Dong , Roberts, Lewis R , Sun, Zhifu

Journal of Korean Medical Science | November 1, 2011 | Volume: 26 | Issue: 11 | Pages: 1428

10.3346/jkms.2011.26.11.1428 Get It